AP2000002017A0 - Salts of paroxetine. - Google Patents

Salts of paroxetine.

Info

Publication number: AP2000002017A0
Authority: AP; ARIPO
Prior art keywords: paroxetine; salts; therapy; preparing; processes
Prior art date: 1998-07-02

Application number

APAP/P/2000/002017A

Other languages

English (en)

Inventor

Victor Witold Jacewicz

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-02

Filing date

1999-06-30

Publication date

2000-12-31

1999-06-30 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-12-31 Publication of AP2000002017A0 publication Critical patent/AP2000002017A0/en

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical class C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003053 piperidines Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

APAP/P/2000/002017A 1998-07-02 1999-06-30 Salts of paroxetine. AP2000002017A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9814316.7A GB9814316D0 (en)	1998-07-02	1998-07-02	Novel compounds
PCT/EP1999/004543 WO2000001692A1 (en)	1998-07-02	1999-06-30	Salts of paroxetine

Publications (1)

Publication Number	Publication Date
AP2000002017A0 true AP2000002017A0 (en)	2000-12-31

Family

ID=10834803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2000/002017A AP2000002017A0 (en)	1998-07-02	1999-06-30	Salts of paroxetine.

Country Status (21)

Country	Link
EP (1)	EP1091958A1 (no)
JP (1)	JP2002519421A (no)
KR (1)	KR20010053337A (no)
CN (1)	CN1314906A (no)
AP (1)	AP2000002017A0 (no)
AU (2)	AU4903999A (no)
BG (1)	BG105204A (no)
BR (1)	BR9911679A (no)
CA (1)	CA2336470A1 (no)
CZ (1)	CZ20004923A3 (no)
EA (1)	EA200100098A1 (no)
GB (1)	GB9814316D0 (no)
HU (1)	HUP0103712A3 (no)
ID (1)	ID27766A (no)
IL (1)	IL140385A0 (no)
NO (1)	NO20006547L (no)
PL (1)	PL345365A1 (no)
SK (1)	SK20242000A3 (no)
TR (1)	TR200100055T2 (no)
WO (1)	WO2000001692A1 (no)
ZA (2)	ZA992899B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1622630T3 (da)	2003-05-07	2012-12-17	Osteologix As	P009368epdk1
ATE342722T1 (de)	2003-05-07	2006-11-15	Osteologix As	Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
PL1732575T3 (pl)	2004-02-26	2011-05-31	Osteologix As	Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
CN101010087B (zh)	2004-05-06	2012-06-27	奥斯泰奥洛吉斯公司	用于制备金属有机盐的高收率和快速的合成方法
KR100672184B1 (ko) *	2004-09-21	2007-01-19	주식회사종근당	파록세틴의 콜린산 또는 콜린산 유도체 염
ES2745411T3 (es) *	2006-07-27	2020-03-02	Wang Nai Fang	Compuestos y composiciones de arilsulfanilo para administración de agentes activos
CN109212055B (zh) *	2018-08-19	2021-05-07	丁立平	一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法
CN109342633B (zh) *	2018-11-27	2020-10-02	北京市化工职业病防治院	尿液中苯、甲苯和二甲苯代谢物的检测方法
CN111337460B (zh) *	2018-12-18	2021-09-17	中国科学院大连化学物理研究所	一种高稳定性Halo-tag探针及其合成和生物应用
CN116283778B (zh) *	2023-02-23	2025-08-29	江苏理工学院	一种吡唑羧酸类化合物及其制备方法和应用
US20250091996A1 (en)	2023-09-15	2025-03-20	King Faisal University	2-(1h-imidazole-1-carbonyl)benzoic acid as an anticancer compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
ES2058061T3 (es) *	1985-10-25	1994-11-01	Beecham Group Plc	Derivado de piperidina, su preparacion y su uso como medicamento.
CA2206592A1 (en) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Method of producing amorphous paroxetine hydrochloride
HU221921B1 (hu) *	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
KR100543614B1 (ko) *	1997-06-10	2006-01-20	신톤 비.브이.	4-페닐피페리딘 화합물
KR20010040711A (ko) *	1998-02-06	2001-05-15	피터 기딩스	파록세틴의 염

1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/xx unknown
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/cs unknown
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/ja active Pending
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/xx unknown
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Ceased
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/hu unknown
- 1999-06-30 EA EA200100098A patent/EA200100098A1/ru unknown
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/sk unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/pt not_active Application Discontinuation
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/ko not_active Withdrawn
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 IL IL14038599A patent/IL140385A0/xx unknown
- 1999-06-30 PL PL99345365A patent/PL345365A1/xx not_active Application Discontinuation
- 1999-06-30 CN CN99810197A patent/CN1314906A/zh active Pending
- 1999-06-30 ID IDW20010252A patent/ID27766A/id unknown
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/no not_active Application Discontinuation
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/xx unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired

Also Published As

Publication number	Publication date
AU4903999A (en)	2000-01-24
EA200100098A1 (ru)	2001-08-27
HUP0103712A3 (en)	2002-09-30
BG105204A (en)	2001-11-30
HUP0103712A2 (hu)	2002-05-29
CA2336470A1 (en)	2000-01-13
BR9911679A (pt)	2002-01-29
WO2000001692A1 (en)	2000-01-13
ZA200100020B (en)	2002-03-25
AU2002100370A4 (en)	2002-06-06
ZA992899B (en)	2000-03-29
ID27766A (id)	2001-04-26
TR200100055T2 (tr)	2001-07-23
SK20242000A3 (sk)	2001-07-10
NO20006547L (no)	2001-02-12
CZ20004923A3 (cs)	2001-08-15
NO20006547D0 (no)	2000-12-21
KR20010053337A (ko)	2001-06-25
GB9814316D0 (en)	1998-09-02
EP1091958A1 (en)	2001-04-18
CN1314906A (zh)	2001-09-26
PL345365A1 (en)	2001-12-17
IL140385A0 (en)	2002-02-10
JP2002519421A (ja)	2002-07-02

Publication	Publication Date	Title
ES2158778A1 (es)	2001-09-01	Compuestos de sales de paroxetina, su preparacion y uso, y composiciones farmaceuticas que los contienen.
BR0016543A (pt)	2002-09-17	Novos derivados de piperidina e piperazina
MY122391A (en)	2006-04-29	Piperazine derivatives as 5-ht1b antagonists
HUP0204515A3 (en)	2005-04-28	4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
SE9704546D0 (sv)	1997-12-05	Novel compounds
BG64475B1 (bg)	2005-04-30	Ципразидонови соли
MY125978A (en)	2006-09-29	Admantane derivatives
SE9900961D0 (sv)	1999-03-16	Novel compounds
HUP0203320A3 (en)	2004-01-28	Indolylpiperidine derivatives and their use as antihistaminic and antiallergic agents, process for their preparation, pharmaceutical compositions containing them
SE9802208D0 (sv)	1998-06-22	Novel compounds
AP2000002017A0 (en)	2000-12-31	Salts of paroxetine.
IL157540A0 (en)	2004-03-28	N-(aryl)-2-arylethenesulphonamides and therapeutic uses thereof
ZA966163B (en)	1997-02-10	Novel galanthamine derivatives, process for the preparation thereof, their application as medical drugs, and pharmaceutical compositions containing said derivatives.
IL180579A0 (en)	2007-06-03	Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
HUP0200133A3 (en)	2003-01-28	Piperidine and piperazine derivatives as inhibitors of the abetha fibril formation, process for their preparation and pharmaceutical compositions containing them
SE9802209D0 (sv)	1998-06-22	Novel compounds
JO2199B1 (en)	2003-12-23	Replaced pyrrols
AU9270598A (en)	1999-04-12	Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
HUP0200412A3 (en)	2002-11-28	New morpholinobenzamide salts, process for their preparation and pharmaceutical compositions containing them and their use
HUP0203161A3 (en)	2003-12-29	Benzamidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
AU5685300A (en)	2001-01-22	Solid preparations containing paroxetine
SE9803107D0 (sv)	1998-09-14	Novel Compunds
EP1221945A4 (en)	2005-06-15	METHOD AND PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS FOR THE ADMINISTRATION OF ADENOSINE
HUP0100661A3 (en)	2002-06-28	Salts of paroxetine, process for their preparation and medicaments containing the compounds
DK1165596T3 (da)	2002-10-14	14,15-alfa-methylen-equileninderivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse